EUVIMEDObjevte EUVIMED
Crossref

Optimality Considerations in Two‐Stage Biomarker‐Stratified Trials With Adaptive Enrichment

Lang Li iD, Anastasia Ivanova

Statistics in Medicine · 2025

DOI: 10.1002/sim.70318 ↗

At a glance

Journal article in Statistics in Medicine, 2025. Written by Lang Li and 1 co-authors. Institution: Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Major MEDLINE topics: Biomarkers, Clinical Trials as Topic, Randomized Controlled Trials as Topic. 31 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

We consider biomarker‐stratified trials that test the treatment effect in a targeted patient group, the biomarker positive subgroup, and in the overall population. If the biomarker negative subgroup is stopped for futility during the interim analysis the number of participants assigned can be increased. Optimal two‐stage designs are obtained using several optimality criteria. Recommendations are given on the best interim analysis timing, futility boundaries, α allocation between the two hypotheses and stage 2 sample size for the biomarker positive subgroup in case its complement, the biomarker negative subgroup, is stopped for futility in the interim analysis. This work is motivated by PrecISE, a two‐stage biomarker‐stratified clinical trial in patients with severe asthma.

Subjects

MeSH terms (MEDLINE)

BiomarkersClinical Trials as TopicRandomized Controlled Trials as TopicHumansAsthmaSample SizeResearch DesignComputer Simulation

Author keywords

adaptive enrichment designbiomarker positive subgroupbiomarker‐stratified trial

Substances

Biomarkers

Authors and institutions

  • Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

ORCID profiles: Lang Li

Cite

APA

Li, L., & Ivanova, A. (2025). Optimality Considerations in Two‐Stage Biomarker‐Stratified Trials With Adaptive Enrichment. Statistics in Medicine. https://doi.org/10.1002/sim.70318

Vancouver

Li L, Ivanova A. Optimality Considerations in Two‐Stage Biomarker‐Stratified Trials With Adaptive Enrichment. Statistics in Medicine. 2025. doi:10.1002/sim.70318

BibTeX
@article{Li2025,
  author = {Li, Lang and Ivanova, Anastasia},
  title = {Optimality Considerations in Two‐Stage Biomarker‐Stratified Trials With Adaptive Enrichment},
  journal = {Statistics in Medicine},
  year = {2025},
  doi = {10.1002/sim.70318}
}
Start for free →